Simvastatin News
Congressmen Examine Web Postings in Vytorin Probe
Anonymous messages posted on a Web site raise questions about the handling of data on a Merck & Co Inc and Schering-Plough Corp cholesterol drug, two U.S. House of Representatives Democrats said on Monday.
FDA Rejects OTC Mevacor (Pharm Aid)
In the blog, the author writes about the not-approvable letter for Merck’s OTC version of the statin Mevacor. The FDA had been reviewing the application for the drug since 1999.
NY Subpoenas Merck, Schering-Plough over Vytorin
New York Attorney General Andrew Cuomo has subpoenaed Merck & Co and Schering-Plough Corp for documents and information to see whether the companies hid the results of a study on their cholesterol drug Vytorin.
Vytorin Prescriptions Down 23% Since Controversial Trial
Prescriptions for Merck & Co.'s (MRK) and Schering- Plough Corp.'s (SGP) embattled cholesterol drug Vytorin have dropped sharply in the two weeks since a study raised questions about its effectiveness, according to a...
Cholesterol-lowering Drugs May be Useful in Prevention of Cancer
A recent study published in the Journal of the National Cancer Institute reports that cholesterol-lowering drugs used in cardiovascular disease prevention have a significant benefit in the prevention of cancer.